Microarray Services
Microarray Service Overview
We work collaboratively with you to achieve your objectives using microarrays. We provide on-time, reliable microarray services, including genotyping and methylation array services, to academic, pharmaceutical, and other customers.
Our in-house experts use cutting-edge Illumina array technologies. You’ll enjoy the same competitive edge our Illumina instrument owners have—conduct whole-genome association studies, linkage analysis, fine mapping studies, and more in a timely fashion at a reasonable cost.
Key Benefits
Microarray services offer the following benefits:
- Personalized service with dedicated and collaborative experts
- Reliable, proven, and rapid processes
- Fully automated
- Integrated with a Laboratory Information Management System (LIMS)
- High-quality data
- Comprehensive study types
Our Microarray Service Offerings
We offer a diverse portfolio of microarray services, include genotyping and methylation array services. Our economical microarray platforms combine high-quality data with a reliable high-throughput process and the content flexibility to match virtually any application. If you're interested in a project with us, talk to your sales representative, or contact us if you have questions.
Contact Us with Questions
Breadth of Experience
We offer years of experience providing services with proven Illumina array technology. Past projects have included genetic disease and cancer applications such as pancreatic, lung and prostate cancer studies, as well as population-based studies in schizophrenia, HIV, and diabetes. Projects have expanded from the research community to biobanks, agriculture, and personal genomics, with offerings for a wide range of sample types.
Additionally, we provide you with personalized attention as your project progresses. Our methylation array and genotyping services can help cost-effectively and rapidly identify variants and epigenetic alterations that contribute to diseases and phenotypes.
COVID-19 Research with Methylation Arrays
Dr. Kathleen Barnes discusses how methylation microarrays add another dimension to the study of COVID-19 and other infectious diseases.
Microarray Service Technology
We use state-of-the-art Illumina array technologies, including whole-genome genotyping and methylation arrays. Custom arrays provide flexible solutions to meet a range of study requirements. Proven array scanning systems image each array, helping scientists unravel the complex genetic architecture behind diseases. Additionally, in-house software SNP selection and analysis tools are used to optimize data precision and research scalability.
Learn more about our microarray technologyMicroarray Service Process
Our reliable automated process guarantees high-quality data delivered in a timely fashion. Our project managers work closely with the project lead throughout the process. Each sample is handled with care from arrival at Illumina to data generation, using a LIMS tracking system for all samples and data.
Multiple QC steps give customers confidence in their data. Each microarray service project is treated with the same level of care for optimal delivery of high-quality data with a fast turnaround time.
Genome-Wide Association Studies (GWAS)
These studies use high-throughput approaches to quickly scan entire genomes of large groups to find genetic variants correlated with a trait or disease.
Learn More About GWAS
Our Team
Our service team includes highly educated scientists and project managers with years of experience in genomics. The team works collaboratively with customers from experimental design through to project completion.
Training
Illumina provides a variety of training options to familiarize you with Illumina microarray analysis and help you manage large datasets.
Explore training optionsIllumina Microarray Service FAQs
Browse frequently asked questions about our services below.
.
Interested in receiving newsletters, case studies, and information from Illumina based on your area of interest? Sign up now.
*Note that we will not accept any samples without a PO and an initial conference call with our project management team.